Cargando…
Valproic acid and HIV-1 latency: beyond the sound bite
A recent publication in Lancet by Dr. David Margolis and colleagues raised the prospect that HIV infection may be curable. In this pilot study, which received much attention from the press, Dr. Margolis'group found that valproic acid plus enfuvirtide reduces the pool of CD4(+ )T-cells, which ar...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242254/ https://www.ncbi.nlm.nih.gov/pubmed/16168066 http://dx.doi.org/10.1186/1742-4690-2-56 |
_version_ | 1782125624677105664 |
---|---|
author | Smith, Stephen M |
author_facet | Smith, Stephen M |
author_sort | Smith, Stephen M |
collection | PubMed |
description | A recent publication in Lancet by Dr. David Margolis and colleagues raised the prospect that HIV infection may be curable. In this pilot study, which received much attention from the press, Dr. Margolis'group found that valproic acid plus enfuvirtide reduces the pool of CD4(+ )T-cells, which are latently infected with HIV-1, the so-called viral reservoir. This commentary critically addresses current data on this topic. |
format | Text |
id | pubmed-1242254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-12422542005-10-06 Valproic acid and HIV-1 latency: beyond the sound bite Smith, Stephen M Retrovirology Commentary A recent publication in Lancet by Dr. David Margolis and colleagues raised the prospect that HIV infection may be curable. In this pilot study, which received much attention from the press, Dr. Margolis'group found that valproic acid plus enfuvirtide reduces the pool of CD4(+ )T-cells, which are latently infected with HIV-1, the so-called viral reservoir. This commentary critically addresses current data on this topic. BioMed Central 2005-09-19 /pmc/articles/PMC1242254/ /pubmed/16168066 http://dx.doi.org/10.1186/1742-4690-2-56 Text en Copyright © 2005 Smith; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Smith, Stephen M Valproic acid and HIV-1 latency: beyond the sound bite |
title | Valproic acid and HIV-1 latency: beyond the sound bite |
title_full | Valproic acid and HIV-1 latency: beyond the sound bite |
title_fullStr | Valproic acid and HIV-1 latency: beyond the sound bite |
title_full_unstemmed | Valproic acid and HIV-1 latency: beyond the sound bite |
title_short | Valproic acid and HIV-1 latency: beyond the sound bite |
title_sort | valproic acid and hiv-1 latency: beyond the sound bite |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242254/ https://www.ncbi.nlm.nih.gov/pubmed/16168066 http://dx.doi.org/10.1186/1742-4690-2-56 |
work_keys_str_mv | AT smithstephenm valproicacidandhiv1latencybeyondthesoundbite |